Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines.

The GameChanger
In addition to medication recommendations, the guidelines now emphasize the role of Community Health Workers in the management of health-related disparities affecting patients with diabetes. Pharmacotherapy continues to be driven by comorbid conditions and the impact of clinical outcomes, like a cardiovascular or renal disease.

Show Segments
00:00 - Introductions
01:59 - Prevention and Delay of Type 2 Diabetes
08:12 - Vaccines and Diabetes
10:49 - Continuous Glucose Monitoring Goals
17:21 - Glycemic Treatment Updates
19:25 - Lipid Goals and Treatment
20:39 - The GameChanger: Treatment Recommendations with Comorbid Conditions
23:49 - Connecting to Practice: Comorbid Driven Therapy
27:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
American Diabetes Association. Standards of Care in Diabetes-2023 Abridged for Primary Care Providers.
 
Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership


CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the goal for continuous glucose monitoring in diabetes patients
2. Describe the lipid goals in patients with diabetes and treatment recommendations
3. Describe treatment recommendations for patients with diabetes and chronic kidney disease

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-102-H01-P
Initial release date: 03/06/2023
Expiration date: 03/06/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram